Labcorp is looking to plug the gap in hepatitis D (HDV) monitoring with a new reflex testing solution to help find more ...
A year after unveiling its first blood test aimed at spotting the signs of a range of neurodegenerative diseases, Labcorp is ramping up its offerings in that realm with the launch of a new, ...
Please provide your email address to receive an email when new articles are posted on . Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug ...
Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for ...
Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE:LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, has launched a new, non-invasive ...
Hosted on MSN
Labcorp to offer first FDA-cleared blood test for initial Alzheimer’s disease assessment
Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results